Search research articles
Contact Us
Filters
Showing results (201-210 of 479) with videos related to
Page
of 48
Sort By:
Pediatric Blood & Cancer
|
May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)
Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
Leukemia
|
September 24, 2004
PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group
M L Loh, M G Reynolds, S Vattikuti, et al.
Leukemia
|
September 27, 2008
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
K Nguyen, M Devidas, S-C Cheng, et al.
Leukemia
|
June 10, 2018
Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells
Sarah K Tasian, Jessica A Casas, David Posocco, et al.
Haematologica
|
June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial
Laura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia
Santhosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 12, 1999
Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age
P J Snyder, H Peachey, P Hannoush, et al.
Nature
|
November 4, 2016
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment
Lei Dong, Wen-Mei Yu, Hong Zheng, et al.
Blood Advances
|
August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at Diagnosis
Mathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Blood
|
February 24, 2006
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01
Mignon L Loh, Meredith A Goldwasser, Lewis B Silverman, et al.
Page
of 48
Search research articles
Search
Showing results (201-210 of 479) with videos related to
Sort By:
Page
of 48
Pediatric Blood & Cancer
|
May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)
Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
Leukemia
|
September 24, 2004
PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group
M L Loh, M G Reynolds, S Vattikuti, et al.
Leukemia
|
September 27, 2008
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
K Nguyen, M Devidas, S-C Cheng, et al.
Leukemia
|
June 10, 2018
Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells
Sarah K Tasian, Jessica A Casas, David Posocco, et al.
Haematologica
|
June 26, 2025
Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group AALL1331 trial
Laura E Hogan, Teena Bhatla, Xinxin Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemia
Santhosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 12, 1999
Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age
P J Snyder, H Peachey, P Hannoush, et al.
Nature
|
November 4, 2016
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment
Lei Dong, Wen-Mei Yu, Hong Zheng, et al.
Blood Advances
|
August 5, 2025
Prognostic Impact of the PredicT-ALL Classifier in the AALL0434 Trial: A Model Combining NGS, MRD and WBC at Diagnosis
Mathieu Simonin, Nicolas Boissel, Arnaud Petit, et al.
Blood
|
February 24, 2006
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01
Mignon L Loh, Meredith A Goldwasser, Lewis B Silverman, et al.
Page
of 48